Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Kappetein AP, et al. Among authors: kirtane aj. Eur Heart J. 2012 Oct;33(19):2403-18. doi: 10.1093/eurheartj/ehs255. Eur Heart J. 2012. PMID: 23026477 Free article.
Stent thrombosis after successful sirolimus-eluting stent implantation.
Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KK, Cohen DJ, Garcia LA, Cutlip DE, Carrozza JP Jr. Jeremias A, et al. Among authors: kirtane aj. Circulation. 2004 Apr 27;109(16):1930-2. doi: 10.1161/01.CIR.0000127105.99982.21. Epub 2004 Apr 12. Circulation. 2004. PMID: 15078797 Clinical Trial.
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, Scirica BM, Jennings LK, Herrmann HC, Cohen DJ, McCabe CH, Braunwald E; TIMI Study Group. Gibson CM, et al. Among authors: kirtane aj. Am Heart J. 2006 Oct;152(4):756-61. doi: 10.1016/j.ahj.2006.04.016. Am Heart J. 2006. PMID: 16996854
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.
Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP Jr, Antman EM, Cannon CP, Gibson CM. Pinto DS, et al. Among authors: kirtane aj. Circulation. 2006 Nov 7;114(19):2019-25. doi: 10.1161/CIRCULATIONAHA.106.638353. Epub 2006 Oct 30. Circulation. 2006. PMID: 17075010
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Stone GW, et al. Among authors: kirtane aj. N Engl J Med. 2007 Mar 8;356(10):998-1008. doi: 10.1056/NEJMoa067193. Epub 2007 Feb 12. N Engl J Med. 2007. PMID: 17296824 Free article.
Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP Jr, Cutlip DE. Kumar R, et al. Among authors: kirtane aj. Am J Cardiol. 2007 Oct 15;100(8):1187-91. doi: 10.1016/j.amjcard.2007.05.038. Epub 2007 Aug 2. Am J Cardiol. 2007. PMID: 17920355
Gender-specific outcomes after sirolimus-eluting stent implantation.
Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R. Solinas E, et al. Among authors: kirtane aj. J Am Coll Cardiol. 2007 Nov 27;50(22):2111-6. doi: 10.1016/j.jacc.2007.06.056. Epub 2007 Nov 13. J Am Coll Cardiol. 2007. PMID: 18036446 Free article. Clinical Trial.
Clinical use of sirolimus-eluting stents.
Kirtane AJ, Leon MB. Kirtane AJ, et al. Cardiovasc Drug Rev. 2007 Winter;25(4):316-32. doi: 10.1111/j.1527-3466.2007.00024.x. Cardiovasc Drug Rev. 2007. PMID: 18078432 Review.
Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings.
Aoki J, Kirtane AJ, Dangas GD, Lansky AJ, Morales A, Kimura M, Kim YH, Moussa I, Weisz G, Kreps EM, Collins M, Frankin-Bond T, Stone GW, Moses JW, Leon MB, Mehran R. Aoki J, et al. Among authors: kirtane aj. Am J Cardiol. 2008 Jan 1;101(1):58-62. doi: 10.1016/j.amjcard.2007.07.049. Epub 2007 Nov 26. Am J Cardiol. 2008. PMID: 18157966
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
Pucelikova T, Mehran R, Kirtane AJ, Kim YH, Fahy M, Weisz G, Lansky AJ, Moussa I, Gray WA, Collins MB, Kodali SK, Stone GW, Moses JW, Leon MB, Dangas G. Pucelikova T, et al. Among authors: kirtane aj. Am J Cardiol. 2008 Jan 1;101(1):63-8. doi: 10.1016/j.amjcard.2007.07.048. Epub 2007 Nov 19. Am J Cardiol. 2008. PMID: 18157967
622 results